ArticleCancer immunology, immunotherapy : CII2022

Metformin inhibits human non-small cell lung cancer by regulating AMPK-CEBPB-PDL1 signaling pathway.

Tao Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.